RE: Outcome of clinical pharmacogenomics task force: "An Ontology-Based, Mobile-Optimized System for Pharmacogenomic Decision Support at the Point-of-Care"

Wonderful! Cheers, -Simon

==================================================
Simon Lin, MD | Director, Biomedical Informatics Research Center | Marshfield Clinic Research Foundation | 1000 N Oak Ave, Marshfield, WI 54449 | 715-221-7299 | Lin.Simon@mcrf.mfldclin.edu<mailto:Lin.Simon@mcrf.mfldclin.edu> | www.marshfieldclinic.org/birc<http://www.marshfieldclinic.org/birc>

From: Matthias Samwald [mailto:matthias.samwald@meduniwien.ac.at]
Sent: Monday, May 05, 2014 3:52 AM
To: public-semweb-lifesci@w3.org
Cc: Yuan Ren; Jeff Z. Pan
Subject: Outcome of clinical pharmacogenomics task force: "An Ontology-Based, Mobile-Optimized System for Pharmacogenomic Decision Support at the Point-of-Care"

Dear all,

Just a quick update on an outcome of work done in the context of the Clinical Pharmacogenomics task force [1]. The following article on using OWL ontologies and reasoning for clinical decision support in pharmacogenomics has now been published in PLoS ONE:

An Ontology-Based, Mobile-Optimized System for Pharmacogenomic Decision Support at the Point-of-Care
Jose Antonio Miñarro-Giménez,  Kathrin Blagec,  Richard D. Boyce,  Klaus-Peter Adlassnig,  Matthias Samwald
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0093769

With kind regards,
Matthias

[1] https://www.w3.org/wiki/HCLSIG/Pharmacogenomics

______________________________________________________________________
The contents of this message may contain private, protected and/or privileged information.  If you received this message in error, you should destroy the e-mail message and any attachments or copies, and you are prohibited from retaining, distributing, disclosing or using any information contained within.  Please contact the sender and advise of the erroneous delivery by return e-mail or telephone.  Thank you for your cooperation.